Cost-Effectiveness of an Adjuvanted Recombinant Zoster Vaccine in Older Adults in the United States Who Have Been Previously Vaccinated With Zoster Vaccine Live

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2018.1558689
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Zoster Vaccine Live

Pharmacotherapy
Pharmacology
2007English

Cost-Effectiveness of the Recommendations of the Advisory Committee on Immunization Practices for the Recombinant Adjuvanted Zoster Subunit Vaccine

JAMA Internal Medicine
Internal Medicine
2018English

Herpes Zoster Vaccine in Older Adults With Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Better Effectiveness of Herpes Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus With Ocular Involvement

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation

JAMA - Journal of the American Medical Association
Medicine
2019English

Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Disseminated Varicella Zoster Virus Infection After Vaccination With a Live Attenuated Vaccine

CMAJ
Medicine
2019English

Exam 3: Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Pin53 - Is the Recombinant Zoster Vaccine Also Cost-Effective for the German Population ≥50 Years of Age?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy